Elevated quetiapine serum concentrations in a patient treated concomitantly with doxepin, lorazepam, and pantoprazole [12]

Journal of Clinical Psychopharmacology

Volumn 24, Issue 5, 2004, Pages 568-571

  Härtter, Sebastian ^a   Connemann, Bernhard ^b   Scḧnfeldt Lecuona, Carlos ^b   Sachse, Julia ^a   Hiemke, Christoph ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; DOXEPIN; LORAZEPAM; PANTOPRAZOLE; QUETIAPINE;

ADULT; AGITATION; AKATHISIA; CASE REPORT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; EXTRAPYRAMIDAL SYMPTOM; HEART ARRHYTHMIA; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PSYCHOSIS; QT PROLONGATION; REFLUX ESOPHAGITIS; RESTLESSNESS;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIPSYCHOTIC AGENTS; BENZIMIDAZOLES; CHRONIC DISEASE; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXEPIN; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ESOPHAGITIS, PEPTIC; HUMANS; LORAZEPAM; MALE; METABOLIC CLEARANCE RATE; OMEPRAZOLE; PROTON PUMPS; SCHIZOPHRENIA; SULFOXIDES;

EID: 4644336025     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000139756.58092.d8     Document Type: Letter

References (17)

1. Small JG, Hirsch SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Arch Gen Psychiatry. 1997;54:549-557.
2. 2 receptor occupancy. Arch Gen Psychiatry. 2000;57:553-559.
3. deVane CL, Nemeroff CB. Clinical Pharmacokinetics of quetiapine. An atypical antipsychotic. Clin Pharmacokinet. 2001;40:509-522.
4. Strakowski SM, Keck PE, Wong YW, et al. The effect of multiple doses of cimetidine on the steady-state pharmacokinetics of quetiapine in men with selected psychotic disorders. J Clin Psychopharmacol. 2002;22:201-205.
5. Potkin SG, Thyrum PT, Alva G, et al. Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine. J Clin Psychopharmacol. 2002;22:174-182.
6. Wong YW, Yeh C, Thyrum PT. The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine. J Clin Psychopharmacol. 2001;21:89-93.
7. Potkin SG, Thyrum PT, Alva G, et al. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine. J Clin Psychopharmacol. 2002;22:121-130.
8. Boulton DW, deVane CL, Liston HL, et al. In vitro P-glycoprotein affinity for atypical and conventional antipsychotics. Life Sci. 2002;71:163-169.
9. Sarkadi B, Price EM, Boucher RC, et al. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J Biol Chem. 1992;267:4854-4858.
10. Drueckes P, Schinzel R, Palm D. Photometric microtiter assay of inorganic phosphate in the presence of acid-labile organic phosphates. Anal Biochem. 1995;230:173-177.
11. Yee S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-Fact or myth. Pharm Res. 1997;14:763-766.
12. Beelen AP, Yeo KT, Lewis LD. Asymptomatic QTc prolongation associated with quetiapine fumarate overdose in a patient being treated with risperidone. Hum Exp Toxicol. 2001;20:215-219.
13. Härtter S, Tybring G, Friedberg T, et al. The N-demethylation of the doxepin isomers is mainly catalyzed by the polymorphic CYP2C19. Pharm Res. 2002;19:1035-1038.
14. Haritos VS, Ghabrial H, Ahokas JT, et al. Role of cytochrome P450 2D6 (CYP2D6) in the stereospecific metabolism of E- and Z-doxepin. Pharmacogenetics. 2000;10:591-603.
15. Tanaka M, Ohkubo T, Otani K, et al. Metabolic disposition of pantoprazole, a proton pump inhibitor, in the relation to S-mephenytoin 4′-hydroxylation phenotype and genotype. Clin Pharmacol Ther. 1997;62:619-628.
16. Huber R, Hartmann M, Bliesath H, et al. Pharmacokinetics of pantoprazole in man. Int J Clin Pharmacol Ther. 1996;34:185-194.
17. Ayton A, Morgan P. Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica. 2001;31:469-497.